The six biggest myths about prostate cancer – as it is named England’s most common cancer - There has been a 25 per cent ...

Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can create confusion.

On Friday, food critic Giles Coren revealed he had this week been diagnosed with the disease. According to Coren, 55, doctors ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

INmune Bio (INMB) has an ongoing Phase I/II trial in men with metastatic castration-resistant prostate cancer. The Company announced the ...

Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of biomarker results in cancer care.